Eur Rev Med Pharmacol Sci 2020; 24 (5): 2781-2783

DOI: 10.26355/eurrev_202003_20551

Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?

M. Ceccarelli, M. Berretta, E. Venanzi Rullo, G. Nunnari, B. Cacopardo

Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. gnunnari@unime.it

Free PDF Download

To cite this article

M. Ceccarelli, M. Berretta, E. Venanzi Rullo, G. Nunnari, B. Cacopardo
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 5
Pages: 2781-2783
DOI: 10.26355/eurrev_202003_20551

Keywords Related articles:

  1. Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?
  2. Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection
  3. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics
  4. Efficacy of continuous renal replacement therapy in the treatment of severe acute pancreatitis associated acute respiratory distress syndrome
  5. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV